Related Experiment Video
Updated: Aug 12, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
[Nosocomial infections. Some aspects]
1Serviço de Medicina 1, Hospital Curry Cabral, Lisboa.
Abstract:
Nosocomial infection is not a recent problem. However, it presents nowadays as a serious issue, not only due to the associated morbidity and mortality but also due to the economic burden on hospitals. The increased susceptibility of patients and the increased resistance to antibiotics by bacterial agents are important factors in the present situation. Among the different nosocomial pathogens, methicillin-resistant Staphylococcus aureus and Clostridium difficile are two of the most distressing for hospitals worldwide. Knowledge of their epidemiology, pathological and clinical particularities and treatment are fundamental in the observation and control of these infections. As a result of my recent experience in two teaching hospitals in the United States of America, I have decided to write the present paper.
Insights
Nosocomial infections pose a significant threat due to patient susceptibility and antibiotic resistance. Understanding the epidemiology and treatment of pathogens like methicillin-resistant Staphylococcus aureus and Clostridium difficile is crucial for control.
Area of Science:
- Infectious Diseases
- Hospital Epidemiology
- Antimicrobial Resistance
Background:
- Nosocomial infections represent a persistent and escalating global health challenge.
- Increased patient susceptibility and rising antibiotic resistance exacerbate the problem.
- Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile are particularly concerning hospital-acquired pathogens.
Purpose of the Study:
- To review the epidemiology, pathology, clinical features, and treatment of key nosocomial pathogens.
- To provide insights based on recent clinical experience in US teaching hospitals.
- To emphasize the importance of knowledge for infection control.
Main Methods:
- Literature review and synthesis of current knowledge on nosocomial infections.
- Analysis of epidemiological data and clinical characteristics of MRSA and C. difficile.
- Discussion of treatment strategies and control measures.
Main Results:
- Nosocomial infections contribute significantly to patient morbidity, mortality, and healthcare costs.
- Antibiotic resistance in bacterial agents is a major driver of current challenges.
- Effective management requires a thorough understanding of specific pathogens.
Conclusions:
- Controlling nosocomial infections necessitates comprehensive knowledge of their epidemiology and clinical aspects.
- Targeted strategies against pathogens like MRSA and C. difficile are essential.
- Continued vigilance and evidence-based practices are fundamental for hospital infection control.
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction

